drugset / Trial / NCT00528593
Epoetin Alfa for HIV-Associated Neuropathy Trial
Phase 2
Withdrawn
Washington University School of Medicine
National Institute of Neurological Disorders and Stroke (NINDS) · collabOrtho Biotech Clinical Affairs, L.L.C. · collabPPD Development, LP · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effect of epoetin alfa on HIV-associated neuropathy by measuring changes in nerve fiber density and pain ratings.
Timeline
- Start
- 2007-11
- Primary completion
- 2009-10
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | epoetin alfa | Protein / enzyme biologic | — | — |